CHINARES PHARMA

03320
4.3851.68% ( -0.075 )
Delay Closed: Nov 20, 16:08:00

Valuation

Current ValuationThe current P/E ratio is 5.76, below the reasonable range, cheaper than 98.16% of the time in the past 5 years, and the industry ranks 3/54, the industry Median 7.34.

5.76xP/E
Stock priceHK$4.39Earnings per shareHK$0.76

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 7.34x
09182736

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 7.34x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
02196HKFOSUN PHARMA
9.25x10.13%HK$37.89B
03320HKCHINARES PHARMA
5.76x7.23%HK$27.55B
01681HKCONSUN PHARMA
9.50x20.92%HK$12.85B
02877HKSHINEWAY PHARM
7.57x13.28%HK$7.01B
02186HKLUYE PHARMA
7.35x47.27%HK$5.89B
02633HKJACOBSON PHARMA
5.90x1.99%HK$1.78B
08049HKJILIN CHANGLONG
6.39x--HK$1.61B
02348HKDAWNRAYS PHARMA
4.82x--HK$1.29B
02161HKJBM HEALTHCARE
6.05x6.78%HK$1.22B
00239HKPAK FAH YEOW
7.34x--HK$726.12M
00950HKLEE'S PHARM
4.94x--HK$591.78M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.